Real-time quantitative analysis of E-cadherin expression in ret/PTC-1-activated thyroid neoplasms

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• Papillary thyroid carcinoma (PTC) is the most common thyroid cancer, typically indolent but with aggressive variants.
• Previous research linked Hashimoto thyroiditis with ret/PTC-1 activation, hypothesizing a role in immune reactions against thyroid epithelium.

Purpose of the Study:

• To investigate E-cadherin expression in various thyroid tumors and Hashimoto thyroiditis.
• To analyze E-cadherin levels in relation to ret/PTC-1 positivity using advanced molecular techniques.

Main Methods:

• Utilized laser capture microdissection for precise tissue sampling.
• Employed TaqMan reverse transcription-polymerase chain reaction (RT-PCR) for gene expression analysis.
• Examined E-cadherin expression across different thyroid tumor types and Hashimoto thyroiditis.

Main Results:

• E-cadherin expression was downregulated in various carcinomas, with anaplastic types showing minimal to no expression.
• Follicular thyroid carcinomas exhibited significantly lower E-cadherin than papillary thyroid carcinomas.
• Papillary thyroid carcinomas with ret/PTC-1 activation (PTCret+) and Hashimoto thyroiditis cases showed reduced E-cadherin compared to ret/PTC-1-negative cases (PTCret-).

Conclusions:

• A significant association exists between ret activation, loss of cellular adhesion (E-cadherin downregulation), and thyroid cancer.
• Findings suggest a notable link between papillary thyroid carcinoma and Hashimoto thyroiditis, potentially mediated by ret/PTC-1 activation.